🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Flu D-QIV

Found 12 matching trials

Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above

PHASE3

The purpose of this study is to evaluate the safety and immunogenicity of G...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-04-29

Trial ID

NCT02369341

Treatments Being Tested

Fluarix Tetra

A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines

N/A

The purpose of this exploratory, retrospective laboratory study is to asses...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-10-26

Trial ID

NCT02415842

Treatments Being Tested

Serum samples

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

PHASE3

The purpose of this study is to evaluate the efficacy, immunogenicity and s...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-10-01

Trial ID

NCT01439360

Treatments Being Tested

Quadrivalent seasonal influenza vaccine(Flu D-QIV) GSK2321138A Havrix Junior Prevenar 13 Varivax/ProVarivax Varilrix

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults

PHASE2

This Phase 2, randomized, observer-blind, antigen and adjuvant dose-ranging...

Status

Completed

Location

03607 - PCRN_Paratus Clinical Research

Start Date

2021-04-13

Trial ID

NCT04782323

Treatments Being Tested

aQII-1 aQII-3 Investigational aQII-6 Investigational aQII-7 Investigational aQII-9 Investigational aQII-10 Investigational aQII-11 Investigational Licensed QII Active Comparator

A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India

PHASE4

The purpose of this study is to gather additional evidence of the safety an...

Status

Completed

Location

GSK Investigational Site

Start Date

2023-12-14

Trial ID

NCT05648357

Treatments Being Tested

Fluarix Tetra Vaccine

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older

PHASE3

The purpose of this study is to investigate the immunogenicity and safety w...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-10-01

Trial ID

NCT02218697

Treatments Being Tested

Influsplit™ Tetra (Fluarix™ Tetra)Pneumovax™ 23 Placebo (Saline)

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults

PHASE2

The purpose of this study is to assess the safety and immune response of Gl...

Status

Completed

Location

GSK Investigational Site

Start Date

2024-05-23

Trial ID

NCT06431607

Treatments Being Tested

F2G22B/DL001Z F2H23D/DL001Z-NH F2H23B/DL001Z-NH F2H23H/DL001Z FDQ23A-NH (Flu D-QIV)GSK5800544A Flu D-TIV F2H23A/DL001Z-NH F2H23G/DL001Z Fluzone HD Quadrivalent Fluzone HD

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

PHASE3

The purpose of this study is to assess immunogenicity, reactogenicity and s...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-10-03

Trial ID

NCT01954251

Treatments Being Tested

Herpes Zoster vaccine GSK 1437173A GSK Biologicals' quadrivalent seasonal influenza vaccine FLU-D-QIV GSK2321138A

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

PHASE3

The aim of this study was to evaluate the immune response and safety of bot...

Status

Completed

Location

GSK Investigational Site

Start Date

2021-10-07

Trial ID

NCT05047770

Treatments Being Tested

HZ/su Flu D-QIV mRNA-1273

A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women.

PHASE3

The purpose of this study is to evaluate the clinical lot-to-lot consistenc...

Status

Completed

Location

GSK Investigational Site

Start Date

2021-10-26

Trial ID

NCT05045144

Treatments Being Tested

RSVPreF3(120 μg)Flu Quadrivalent influenza vaccine (15 μg HA)Placebo

Previous Next